In the BioHarmony Drug Report Database

"Preview" Icon

Doripenem

Doribax (doripenem) is a small molecule pharmaceutical. Doripenem was first approved as Doribax on 2007-10-12. It is used to treat bacterial infections, intraabdominal infections, and urinary tract infections in the USA. Doribax’s patent is valid until 2021-03-30 (FDA).

 

Trade Name

 

Doribax
 

Common Name

 

doripenem
 

ChEMBL ID

 

CHEMBL491571
 

Indication

 

bacterial infections, intraabdominal infections, urinary tract infections
 

Drug Class

 

Antibacterial antibiotics, carbapenem derivatives

Image (chem structure or protein)

Doripenem structure rendering